Angiotech Pharmaceuticals, Inc.
Enrollment in Taxus V clinical trial concluded
Published in Patient Care Law Weekly, May 2nd, 2004
Boston announced that it has enrolled 1172 patients, surpassing the required sample size of 1108. The U.S. Food and Drug Administration (FDA) has confirmed that the company has reached sufficient enrollment to meet all the required trial analyses, and that it may therefore close enrollment in the trial.
The Taxus V clinical trial expands on the Taxus IV trial, which established the safety and efficacy of the Taxus Express(2) paclitaxel-eluting stent system. Taxus V is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Patient Care Law Weekly
More Articles from Patient Care Law Weekly
- Abortion
Doctor testifies that banned type of abortion needs more study - Adoption Issues
Oklahoma health department to issue birth certificates to same-sex couples - Alza Corp.
Mylan loses patent infringement suit - Barr Laboratories, Inc.
Kos files suit for infringement of new Niaspan patent - Breast Cancer
Exposure to famine associated with increased cancer risk - Ciphergen Biosystems, Inc.
Data on disease-specific inflammatory diagnostics reported at cancer meeting - More from this issue of Patient Care Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
